Tropolone derivative hinokitiol ameliorates cerulein-induced acute pancreatitis in mice.
Acute Disease
Animals
Anti-Inflammatory Agents
/ pharmacology
Ceruletide
/ pharmacology
Cytokines
/ metabolism
Disease Models, Animal
Mice
Monoterpenes
NF-kappa B
/ metabolism
Pancreas
/ pathology
Pancreatitis
/ chemically induced
Tropolone
/ analogs & derivatives
Tumor Necrosis Factor-alpha
/ metabolism
Acute pancreatitis
Hinokitiol
Inflammation
Injury
Oxidative stress
Journal
International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
17
12
2021
revised:
25
05
2022
accepted:
29
05
2022
pubmed:
10
6
2022
medline:
22
6
2022
entrez:
9
6
2022
Statut:
ppublish
Résumé
Hinokitiol is a natural bio-active tropolone derivative with promising antioxidant and anti-inflammatory properties. This study was conducted to evaluate the ameliorative effects of hinokitiol against acute pancreatitis induced by cerulein. Mice were pre-treated with hinokitiol intraperitoneally for 7 days (50 and 100 mg/kg), and on the final day of study, cerulein (6 × 50 μg/kg) was injected every hour for six times. Six hours after the last dose of cerulein, blood was collected from the mice through retro-orbital plexus for biochemical analysis. After blood collection, mice were euthanized and the pancreas was harvested for studying effects on oxidative stress, pro-inflammatory cytokines, immunohistochemistry and histopathology of tissue sections. Hinokitiol treatment significantly reduced edema of the pancreas and reduced the plasma levels of lipase and amylase in mice with cerulein-induced acute pancreatitis. It also attenuated the oxidative and nitrosative stress related damage as evident from the reduced malondialdehyde (MDA) and nitrite levels, which were significantly increased in the mice with acute pancreatitis. Furthermore, hinokitiol administration significantly reduced the pancreatitis-evoked decrease in the activity of catalase, glutathione (GSH) and superoxide dismutase (SOD) in the pancreatic tissue. Pre-treatment with hinokitiol significantly reduced the elevated levels of pro-inflammatory cytokines like interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-alpha (TNF-α) as well as increased the levels of anti-inflammatory cytokine interleukin-10 (IL-10) in the pancreatic tissue of mice with acute pancreatitis. The immunohistochemical expression of nuclear factor kappa light chain enhancer of activated B cells (NF-κB), cyclooxygenase (COX-2) and TNF-α were significantly decreased by hinokitiol in mice with cerulein-induced acute pancreatitis. In conclusion, the results of the present study demonstrate that hinokitiol has significant potential to prevent cerulein-induced acute pancreatitis.
Identifiants
pubmed: 35679663
pii: S1567-5769(22)00399-X
doi: 10.1016/j.intimp.2022.108915
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Cytokines
0
Monoterpenes
0
NF-kappa B
0
Tumor Necrosis Factor-alpha
0
Tropolone
7L6DL16P1T
Ceruletide
888Y08971B
beta-thujaplicin
U5335D6EBI
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108915Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.